Glaxosmithkline
- All
- News
- Videos
-
Pharma Giant GSK Fires Employee After Video Of His Abusive Meltdown On Flight Goes Viral
A man in the United States was fired from his job after being caught on video yelling homophobic, racist slurs during a flight.
-
Eye On Investment, Telangana Minister KTR Meets UK Healthcare Giant
Telangana Minister KT Rama Rao on Thursday held a meeting with Global R&D Head GSK Consumer Health, Franck Riot and discussed the expansion plans of GlaxoSmithKline, a healthcare company, for the state.
-
Unilever Announces Job Cuts Globally Amid Restructuring
Unilever on Tuesday announced plans to cut around 1,500 management jobs worldwide under a major restructure of the British consumer goods giant
-
CCI Okays Acquisition Of 100% Shares In GlaxoSmithKline Asia By Parent Group Entities
CCI has okayed the acquisition of GlaxoSmithKline Asia Private Limited shareholding by parent group companies
-
Unilever Shows Interest In GSK's Consumer Health Business
Dove soap maker Unilever signalled on Monday it would pursue a deal for GlaxoSmithKline's consumer health business
-
2 New Medicines For Covid Treatment Get WHO Approval
Eli Lilly & Co.'s rheumatoid arthritis drug and GlaxoSmithKline Plc's monoclonal antibody won the backing of World Health Organization experts for treating Covid-19 as new infections surge across the globe.
-
All 37 Omicron Mutations Defeated By This New Antibody Treatment
GlaxoSmithKline Plc said research shows its Covid-19 antibody treatment is effective against the full combination of mutations in the new omicron variant.
-
UK Approves GlaxoSmithKline Drug, Appears Effective Against Omicron
British regulators on Thursday approved GlaxoSmithKline drug sotrovimab to treat those at high risk of developing severe Covid-19 symptoms, with the manufacturer saying it "retains activity" against the new Omicron variant.
-
GlaxoSmithKline, SK Bioscience Start Final Trial Of COVID-19 Jab
British drugs giant GlaxoSmithKline and South Korean peer SK bioscience have begun final stage trials of a Covid-19 jab after positive early results, they announced Tuesday.
-
Sanofi, GlaxoSmithKline Get India's Approval For Late-Stage Vaccine Trial
Sanofi SA and GlaxoSmithKline Plc have received an approval from Indian authorities for a late-stage clinical trial of their protein-based COVID-19 vaccine candidate, the drugmakers said on Thursday.
-
Sanofi To Invest 400 Million Euros In A mRNA Vaccines Facility
The French drug giant and its British counterpart GlaxoSmithKline surprised investors and customers last year when they announced a one-year delay to the launch of their joint COVID vaccine, based on a more conventional technology.
-
GSK Pharma Net Profit Falls 90% To Rs 14 Crore In March Quarter
GSK Pharma Q4 Results: GlaxoSmithKline (GSK) Pharmaceuticals reported a net profit of Rs 14.33 crore in the January-March quarter for the financial year 2020-21
-
Wall Street Banks See Rare Payday Bonanza In India Despite Pandemic
India has seen a number of multi-billion dollar transactions in 2020 from oil-to-telecom conglomerate Reliance Industries' fundraising efforts to GlaxoSmithKline's sale of its stake in Unilever's Indian business.
-
Glaxo Head Optimistic COVID-19 Vaccine Widely Available In 2021
The chief executive of GlaxoSmithKline, the world's largest maker of vaccines, said she was optimistic the industry will be able to make an immunisation against COVID-19 widely available next year.
-
Pentagon Awards Glaxo $342 Million Contract For COVID Vaccines
The Pentagon on Thursday announced a $342 million contract has been awarded to British pharmaceutical giant GlaxoSmithKline to deliver "mass quantities of COVID-19 vaccines" to US troops.
-
Pharma Giant GSK Fires Employee After Video Of His Abusive Meltdown On Flight Goes Viral
A man in the United States was fired from his job after being caught on video yelling homophobic, racist slurs during a flight.
-
Eye On Investment, Telangana Minister KTR Meets UK Healthcare Giant
Telangana Minister KT Rama Rao on Thursday held a meeting with Global R&D Head GSK Consumer Health, Franck Riot and discussed the expansion plans of GlaxoSmithKline, a healthcare company, for the state.
-
Unilever Announces Job Cuts Globally Amid Restructuring
Unilever on Tuesday announced plans to cut around 1,500 management jobs worldwide under a major restructure of the British consumer goods giant
-
CCI Okays Acquisition Of 100% Shares In GlaxoSmithKline Asia By Parent Group Entities
CCI has okayed the acquisition of GlaxoSmithKline Asia Private Limited shareholding by parent group companies
-
Unilever Shows Interest In GSK's Consumer Health Business
Dove soap maker Unilever signalled on Monday it would pursue a deal for GlaxoSmithKline's consumer health business
-
2 New Medicines For Covid Treatment Get WHO Approval
Eli Lilly & Co.'s rheumatoid arthritis drug and GlaxoSmithKline Plc's monoclonal antibody won the backing of World Health Organization experts for treating Covid-19 as new infections surge across the globe.
-
All 37 Omicron Mutations Defeated By This New Antibody Treatment
GlaxoSmithKline Plc said research shows its Covid-19 antibody treatment is effective against the full combination of mutations in the new omicron variant.
-
UK Approves GlaxoSmithKline Drug, Appears Effective Against Omicron
British regulators on Thursday approved GlaxoSmithKline drug sotrovimab to treat those at high risk of developing severe Covid-19 symptoms, with the manufacturer saying it "retains activity" against the new Omicron variant.
-
GlaxoSmithKline, SK Bioscience Start Final Trial Of COVID-19 Jab
British drugs giant GlaxoSmithKline and South Korean peer SK bioscience have begun final stage trials of a Covid-19 jab after positive early results, they announced Tuesday.
-
Sanofi, GlaxoSmithKline Get India's Approval For Late-Stage Vaccine Trial
Sanofi SA and GlaxoSmithKline Plc have received an approval from Indian authorities for a late-stage clinical trial of their protein-based COVID-19 vaccine candidate, the drugmakers said on Thursday.
-
Sanofi To Invest 400 Million Euros In A mRNA Vaccines Facility
The French drug giant and its British counterpart GlaxoSmithKline surprised investors and customers last year when they announced a one-year delay to the launch of their joint COVID vaccine, based on a more conventional technology.
-
GSK Pharma Net Profit Falls 90% To Rs 14 Crore In March Quarter
GSK Pharma Q4 Results: GlaxoSmithKline (GSK) Pharmaceuticals reported a net profit of Rs 14.33 crore in the January-March quarter for the financial year 2020-21
-
Wall Street Banks See Rare Payday Bonanza In India Despite Pandemic
India has seen a number of multi-billion dollar transactions in 2020 from oil-to-telecom conglomerate Reliance Industries' fundraising efforts to GlaxoSmithKline's sale of its stake in Unilever's Indian business.
-
Glaxo Head Optimistic COVID-19 Vaccine Widely Available In 2021
The chief executive of GlaxoSmithKline, the world's largest maker of vaccines, said she was optimistic the industry will be able to make an immunisation against COVID-19 widely available next year.
-
Pentagon Awards Glaxo $342 Million Contract For COVID Vaccines
The Pentagon on Thursday announced a $342 million contract has been awarded to British pharmaceutical giant GlaxoSmithKline to deliver "mass quantities of COVID-19 vaccines" to US troops.
